{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "15270564", "DateCompleted": {"Year": "2004", "Month": "09", "Day": "08"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "67", "Issue": "7", "PubDate": {"Year": "2004", "Month": "Jul"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "New crinine-type alkaloids with inhibitory effect on induction of inducible nitric oxide synthase from Crinum yemense.", "Pagination": {"StartPage": "1119", "EndPage": "1124", "MedlinePgn": "1119-24"}, "Abstract": {"AbstractText": ["The 80% aqueous methanolic extract from the bulbs of Crinum yemense showed a potent inhibitory effect on nitric oxide production in lipopolysaccharide-activated macrophages. Three new crinine-type alkaloids, yemenines A (1), B (2), and C (3), were isolated from the herbal extract together with six known alkaloids. The absolute configurations of 1-3 were determined on the basis of chemical and physicochemical evidence. The effects of the isolated alkaloids on nitric oxide production in lipopolysaccharide-activated macrophages were examined, and several alkaloids, e.g. 1, (+)-bulbispermine (6), (+)-crinamine (7), (+)-6-hydroxycrinamine (8), and (-)-lycorine (9), showed inhibitory effects on nitric oxide production and induction of inducible nitric oxide synthase."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt."}], "Identifier": [], "LastName": "Abdel-Halim", "ForeName": "Osama Bashir", "Initials": "OB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Morikawa", "ForeName": "Toshio", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ando", "ForeName": "Shin", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Matsuda", "ForeName": "Hisashi", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yoshikawa", "ForeName": "Masayuki", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Amaryllidaceae Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Indolizines"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenanthridines"}, {"RegistryNumber": "0", "NameOfSubstance": "yemenine A"}, {"RegistryNumber": "0", "NameOfSubstance": "yemenine B"}, {"RegistryNumber": "0", "NameOfSubstance": "yemenine C"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "639-41-8", "NameOfSubstance": "crinamine"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type II"}, {"RegistryNumber": "I9Q105R5BU", "NameOfSubstance": "lycorine"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Amaryllidaceae Alkaloids"}, {"QualifierName": ["chemistry"], "DescriptorName": "Crinum"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Indolizines"}, {"QualifierName": ["metabolism"], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": ["drug effects"], "DescriptorName": "Macrophages, Peritoneal"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Nitric Oxide Synthase"}, {"QualifierName": [], "DescriptorName": "Nitric Oxide Synthase Type II"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Phenanthridines"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Yemen"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2004", "Month": "7", "Day": "24", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "9", "Day": "9", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "7", "Day": "24", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["15270564", "10.1021/np030529k"]}}], "PubmedBookArticle": []}